Real-World Effectiveness of a Digital Therapeutic in Improving Glycaemic Control in South Asians Living with Type 2 Diabetes
The DOI matches its Crossref record.
Abstract
Background: Insurers in South Asia are challenged by lack of a culturally relevant and clinically effective lifestyle intervention that can be delivered at scale. This study reports results from participants of a real-world pilot using Wellthy Diabetes™ (WD), a digital therapeutic for people living with type 2 diabetes, in collaboration with an insurance provider with the aim to validate WD as a diabetes management and risk reduction tool. WD was developed in scientific collaboration with the Research Society for Study of Diabetes in India (RSSDI). Methods: A 16-week lifestyle modification program was delivered to persons with T2DM through an Artificial Intelligence (AI) powered smartphone app. The program included behavioral modification training based on structured DSME content, developed along AADE7™ guidelines. The WD app enables users to self-report data on blood glucose, weight, meals, and physical activity and encourages logging through personalized reminders and nudges using an AI-powered digital persuasion model. Participants received real-time feedback and coaching through an AI-powered chatbot and personalized coaching from an expert diabetes coach. A1c measures were conducted at the start and end of the program. This study presents results from 102 program completers who completed follow-up A1c. Results: The mean pre and post-intervention A1c for 102 program completers (mean age: 50.8 years and 68% males) were 8.51% (95% CI:8.23-8.79) and 8.02% (95% CI: 7.72-8.32), respectively, showing a mean post-intervention reduction of -0.49% A1c (95% CI:-0.73 - -0.25, p=0.01). Sixty percent (n=61) of participants reduced their A1c by the end of the program with a mean reduction of -1.17% A1c (95% CI: 0.75-1.60). Conclusion: This study demonstrates Wellthy Diabetes as a clinically effective intervention for Health and Life Insurers in South Asia to improve health outcomes and reduce risk for people with type 2 diabetes through improved glycemic control. Disclosure: A.R. Sosale: None. M. Shaikh: Employee; Self; Wellthy Therapeutics Pvt Ltd. A. Shah: Stock/Shareholder; Self; Wellthy Therapeutics.R. Chawla: None.B.M. Makkar: None. J. Kesavadev: Advisory Panel; Self; Novo Nordisk India Private Limited. Speaker's Bureau; Self; Novo Nordisk India Private Limited. Advisory Panel; Self; Medtronic. Speaker's Bureau; Self; Medtronic. Advisory Panel; Self; Sanofi. Speaker's Bureau; Self; Sanofi. Research Support; Self; MSD. Speaker's Bureau; Self; MSD. Advisory Panel; Self; AstraZeneca. Speaker's Bureau; Self; AstraZeneca.S. Joshi: None.N. Deshpande: None.S. Agarwal: None.A. Maheshwari: None.S. Madhu: None.B.D. Saboo: None.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The effectiveness of health care conversational agents was assessed in 8 studies [47,52,57,61,70,75,81,84].”
From Conversational Agents in Health Care: Scoping Review and Conceptual Analysis (2020) · cites this paper as [70]
In the citing paper
“Shaikh et al [70] reported successful reduction in HbA1c (glycated hemoglobin) levels postengagement with Wellthy diabetes”
From Conversational Agents in Health Care: Scoping Review and Conceptual Analysis (2020) · cites this paper as [70]
Citations
Cites
Still being checked.
Cited by
Conversational Agents in Health Care: Scoping Review and Conceptual Analysis
Tudor Car, L., Dhinagaran, D. A., Kyaw, B. M., Kowatsch, T., Joty, S., Theng, Y.-L., & Atun, R. (2020) · Journal of Medical Internet Research · doi:10.2196/17158 · Cited by 553
“Moreover, 8 studies originated from Asian countries: Philippines [65], China [66], Japan [67,68], Pakistan [69], India [70,71], and Hong Kong [72].”
BackgroundInfluentialBassi, G., Donadello, I., Gabrielli, S., Salcuni, S., Giuliano, C., & Forti, S. (2021) · JMIR Formative Research · doi:10.2196/27500 · Cited by 5
Keller, R., Yao, J., Teepe, G. W., Hartmann, S., Lohse, K.-M., von Wangenheim, F., Müller‐Riemenschneider, F., Mair, J. L., & Kowatsch, T. (2021) · International Joint Conference on Biomedical Engineering Systems and Technologies (BIOSTEC) · doi:10.5220/0010412708110816 · Cited by 4
Dhinagaran, D. A. (2022) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/163179
An intention-oriented multi-agent dialogue system for patient-centered decision-making
Liu, P., & Xiao, L. (2026) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-026-03498-x
Metadata
- Authors
- SOSALE, A. R., SHAIKH, M., SHAH, A., CHAWLA, R., MAKKAR, B. M., KESAVADEV, J., JOSHI, S., DESHPANDE, N., AGARWAL, S., MAHESHWARI, A., MADHU, S., & SABOO, B. D.
- Affiliations
- Bangalore, India, Mumbai, India, New Delhi, India, Delhi, India, Trivandrum, India, Belgaum, India, Pune, India, Lucknow, India, Ahmedabad, India
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2018-07-01
- Volume
- 67
- Issue
- Supplement_1
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2809619358
- Cited by
- 5
- References
- 0
- Citations by year
- 2026: 1 · 2022: 1 · 2021: 2 · 2020: 1
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- Topics
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Keywords
- type 2 diabetes, digital therapeutics, glycemic control, HbA1c, lifestyle modification, artificial intelligence, mobile application, chatbots, nudging, diabetes self-management education, health insurance, South Asians, real-world effectiveness, behavior change, personalized coaching, risk mitigation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Real-World Effectiveness of a Digital Therapeutic in Improving Glycaemic Control in South Asians Living with Type 2 Diabetes. https://app.cochat.ai/papers/10.2337/db18-866-p
- The paper
- SOSALE, A. R., SHAIKH, M., SHAH, A., CHAWLA, R., MAKKAR, B. M., KESAVADEV, J., JOSHI, S., DESHPANDE, N., AGARWAL, S., MAHESHWARI, A., MADHU, S., & SABOO, B. D. (2018). Real-World Effectiveness of a Digital Therapeutic in Improving Glycaemic Control in South Asians Living with Type 2 Diabetes. Diabetes. https://doi.org/10.2337/db18-866-p
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.